Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.The Serie's long term average value is -0.5 Billion United States Dollars. It's latest available value, on 09/30/2025, is 0.727 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 09/30/2018, to it's latest available value, on 09/30/2025, is +1.26 Billion.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Other Finance Cost | 905,699,262,464.00 |
![]() | AbbVie Inc - Total Other Finance Cost | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Other Finance Cost | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Other Finance Cost | 280,205,508,085.11 |
![]() | Novartis AG - Total Other Finance Cost | 255,096,620,580.91 |